Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -2020/21 parent results

May 7 (Reuters)- 
          Kainos Laboratories Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           4.26            4.61           4.60          2.23    
               (-7.6 pct)      (-1.3 pct)     (+8.0 pct)    (+6.9 pct) 
  Operating      632 mln         608 mln        600 mln      300 mln   
               (+3.9 pct)      (+4.7 pct)     (-5.1 pct)    (-6.4 pct) 
  Recurring      653 mln         616 mln        600 mln      300 mln   
               (+6.1 pct)      (+3.3 pct)     (-8.2 pct)    (-8.0 pct) 
  Net            417 mln         398 mln        400 mln      200 mln   
               (+4.7 pct)      (+3.3 pct)     (-4.2 pct)    (-0.5 pct) 
  EPS          100.63 yen       97.09 yen      97.71 yen    48.86 yen  
  Ann Div       15.00 yen       15.00 yen      15.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       15.00 yen       15.00 yen      15.00 yen               
  
  NOTE - Kainos Laboratories Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T

Recent news on Kainos Laboratories

See all news